ARTICLE | Clinical News
Greenwich Pharmaceuticals Inc regulatory update
March 22, 1993 8:00 AM UTC
Greenwich Pharmaceuticals Inc. (GRPI) Greenwich Pharmaceuticals Inc. (GRPI) filed an NDA with the FDA for Therafectin, used as a chronic treatment for the signs and symptoms of rheumatoid arthritis. ...